Globestar Therapeutics CORP 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OTC.Pink
10-K: GlobeStar Therapeutics Corporation Files 10-K Annual Report, Outlines Path Forward for MS Treatment
GlobeStar Therapeutics Corporation has filed its annual report on Form 10-K for the fiscal year ended September 30, 2023, detailing its financial status and strategic initiatives, particularly in the development of a patented multiple sclerosis treatment.